drugset / Trial / NCT06835465
A Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Divarasib in Healthy Participants
Non-randomizedCrossoverOpen-labelBasic science
Summary
This is a phase 1, open-label, two-period, fixed sequence drug-drug interaction study to evaluate the impact of multiple doses of rifampin on the pharmacokinetics (PK) and safety of divarasib in healthy participants.
Timeline
- Start
- 2025-02-21
- Primary completion
- 2025-05-06
- Completion
- 2025-05-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Divarasib | Small molecule | — | Oral |
| Subject | Rifampin | Small molecule | — | Oral |
Indications
No indication recorded.